Evidence map›Paper›PMID 20815868›Full record

ReviewBMC psychiatry2010

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Sandra J J Kooij, Susanne Bejerot, Andrew Blackwell, Herve Caci, Miquel Casas-Brugué, Pieter J Carpentier, Dan Edvinsson, John Fayyad, Karin Foeken, Michael Fitzgerald and 17 more

Registry-linked trialOpen access · goldAbstract readComparative StudyReviewConsensus Statement
In one paragraph

Review in BMC psychiatry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05916339 (Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder), which is not on this map. Cited by 284 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
284citing papers in PubMed, 17 pooled it
25.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05916339 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder

TypeinterventionalSponsorDaniel CouryRan2023 to 2027Enrolled500ConditionsADHD, Autism Spectrum DisorderArmsRandomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
3 · Its place in the literature

Who cites it

284 citing papers in PubMed, 17 syntheses or guidelines pooled it, 906 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  13. Pooled it
  14. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Trial
  20. Trial

224 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 13 countries.

Sandra J J KooijPsyQ, psycho medische programma's, Department Adult ADHD, Carel Reinierszkade 197, Den Haag, The Netherlands. s.kooij@psyq.nl
Susanne Bejerot
Andrew Blackwell
Herve Caci
Miquel Casas-Brugué
Pieter J Carpentier
Dan Edvinsson
John Fayyad
Karin Foeken
Michael Fitzgerald
Veronique Gaillac
Ylva Ginsberg
Chantal Henry
Johanna Krause
Michael B Lensing
Iris Manor
Helmut Niederhofer
Carlos Nunes-Filipe
Martin D Ohlmeier
Pierre Oswald
Stefano Pallanti
Artemios Pehlivanidis
Josep A Ramos-Quiroga
Maria Rastam
Doris Ryffel-Rawak
Steven Stes
Philip Asherson
Addenbrooke's Hospital · GBCentre Hospitalier Charles Perrens · FRCentre Hospitalier Sainte-Anne · FRFondation Lenval · FRInstitut Arnault Tzanck · FRInstitute for Development, Research, Advocacy and Applied Care · LBKing's College London · GBLund University · SEMedizinische Hochschule Hannover · DEMedprevent Ottobrunn · DEOslo University Hospital · NOOspedale di Bolzano · ITPsyQ · NLReinier van Arkel · NLTel Aviv University · ILTrinity College Dublin · IEUniversidade Nova de Lisboa · PTUniversitat Autònoma de Barcelona · ESUniversité Libre de Bruxelles · BEUniversity of Florence · IT

Funding

Department of Health RP-PG-0606-1045Medical Research Council G0400061
6 · The paper itself

Abstract

backgroundAttention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe.

methodsThe European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe. This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated.

resultsBesides information on the genetics and neurobiology of ADHD, three major questions are addressed in this statement: (1) What is the clinical picture of ADHD in adults? (2) How can ADHD in adults be properly diagnosed? (3) How should ADHD in adults be effectively treated?

conclusionsADHD often presents as an impairing lifelong condition in adults, yet it is currently underdiagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group.

Indexed as

ConsensusAdolescentAdultAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildCombined Modality TherapyDisease ProgressionEuropeFemaleHumansMalePractice Guidelines as TopicPsychotherapyCentral Nervous System Stimulants

Identifiers

PMID20815868
PMCPMC2942810
OpenAlexW2137706707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.